| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4242093 | Journal of Vascular and Interventional Radiology | 2009 | 4 Pages |
Abstract
Wound dehiscence after port placement was related to timing of bevacizumab therapy. Patients receiving bevacizumab within 10 days of port placement had a higher incidence of wound dehiscence.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Walter J. NP, T. Gregory MD, Emily RN, Elkan F. PhD, Arthur C. MD, Stephan T. MD, David P. MD, Sanjeeva P. MD,